Ceftriaxone therapy of serious bacterial infections in adults.
We evaluated the efficacy and safety of ceftriaxone in 50 adults with serious infections, usually giving 1 g every 12 h. Of the 35 patients who could be evaluated for clinical efficacy, 15 had failed on previous therapy, 15 had nosocomial infections, and all but 1 had underlying diseases. One patien...
Spremljeno u:
| Izdano u: | Antimicrob Agents Chemother |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology (ASM)
1983
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC186034/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6301365/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.23.2.261 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
